Symphogen A/S Appoints Christian Meyer Vice President Of Clinical Development

COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen announced today that Christian Meyer, M.D., Ph.D., has been appointed Vice President of Clinical Development. In this role, Dr. Meyer will lead Symphogen’s clinical development activities for its portfolio of recombinant polyclonal antibody product candidates and programs. The Company also announced the appointment of Henrik Rasmussen, M.D., Ph.D., of Nabi Biopharmaceuticals to its Medical Advisory Board.

MORE ON THIS TOPIC